Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p30
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 30/66)
Character Range: 82863–85798

the column headed "Circumstances" (all instances): C4246
(b) omit from the column headed "Circumstances" (all instances): C5856
[200] Schedule 1, Part 1, entries for Olanzapine in the form Tablet 5 mg (orally disintegrating)
(a) insert in numerical order in the column headed "Circumstances" (all instances): C4246
(b) omit from the column headed "Circumstances" (all instances): C5856
[201] Schedule 1, Part 1, entries for Olanzapine in the form Tablet 7.5 mg
(a) insert in numerical order in the column headed "Circumstances" (all instances): C4246
(b) omit from the column headed "Circumstances" (all instances): C5856
[202] Schedule 1, Part 1, entries for Olanzapine in the form Tablet 10 mg
(a) insert in numerical order in the column headed "Circumstances" (all instances): C4246
(b) omit from the column headed "Circumstances" (all instances): C5856
[203] Schedule 1, Part 1, entries for Olanzapine in the form Tablet 10 mg (orally disintegrating)
(a) insert in numerical order in the column headed "Circumstances" (all instances): C4246
(b) omit from the column headed "Circumstances" (all instances): C5856
[204] Schedule 1, Part 1, entries for Olanzapine in the form Tablet 15 mg (orally disintegrating)
(a) insert in numerical order in the column headed "Circumstances" (all instances): C4246
(b) omit from the column headed "Circumstances" (all instances): C5856
[205] Schedule 1, Part 1, entries for Olanzapine in the form Tablet 20 mg (orally disintegrating)
(a) insert in numerical order in the column headed "Circumstances" (all instances): C4246
(b) omit from the column headed "Circumstances" (all instances): C5856
[206] Schedule 1, Part 1, entry for Olanzapine in each of the forms: Wafer 5 mg; Wafer 10 mg; Wafer 15 mg; and Wafer 20 mg
(a) insert in numerical order in the column headed "Circumstances": C4246
(b) omit from the column headed "Circumstances": C5856
[207] Schedule 1, Part 1, entries for Ozanimod
omit from the column headed "Responsible Person" (all instances): CJ  substitute (all instances): BQ
[208] Schedule 1, Part 1, after entry for Pantoprazole in the form Tablet (enteric coated) 20 mg (as sodium sesquihydrate) [Brand: APO-Pantoprazole; Maximum Quantity: 60; Number of Repeats: 5]
insert:
Pantoprazole  Tablet (enteric coated) 20 mg (as sodium sesquihydrate)  Oral  APX-PANTOPRAZOLE  TW  MP NP  C5444 C5512 C5529     P5444 P5512 P5529     30  5     30
Pantoprazole  Tablet (enteric coated) 20 mg (as sodium sesquihydrate)  Oral  APX-PANTOPRAZOLE  TW  MP NP  C15574 C15575 C15633  P15574 P15575 P15633  60  5     30

[209] Schedule 1, Part 1, entries for Paracetamol in the form Tablet 665 mg (modified release) [Brand: Parapane OSTEO]
omit from the column headed "Responsible Person" (all instances): AF  substitute (all instances): XT
[210] Schedule 1, Part 1, entry for Penicillamine in the form Tablet 125 mg [Maximum Quantity: 100; Number of Repeats: 1]
(a) insert in the column headed